Indianapolis, IN, United States of America

Holly M Hankins


Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 1996-1997

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Holly M Hankins

Introduction

Holly M Hankins, an accomplished inventor based in Indianapolis, IN, has made significant contributions to the field of pharmaceuticals through her innovative work. With a total of two patents to her name, she has focused on enhancing the formulation and efficacy of dirithromycin, a crucial antibiotic.

Latest Patents

Hankins' latest patents include a "Process for preparing crystal forms and solvates of dirithromycin." This invention introduces Form II dirithromycin, a novel polymorph of dirithromycin, along with several solvates such as acetone, 1-butanol, 1-propanol, and 2-propanol. Her work offers efficient methods for preparing and isolating Form II from both these solvates and from Form I dirithromycin. Additionally, her patents encompass a process for obtaining Form II dirithromycin from non-solvated dirithromycin, as well as an improved tablet formulation containing Form II dirithromycin as the active ingredient.

Career Highlights

Currently, Holly M Hankins is employed at Eli Lilly and Company, where she has been able to translate her innovative ideas into practical applications in the pharmaceutical industry. Her dedication to improving drug formulations has set her apart as a prominent figure in her field.

Collaborations

Throughout her career, Hankins has collaborated with numerous professionals, including esteemed coworkers such as James M Greene and Gregory Alan Stephenson. These partnerships have allowed her to enhance her research and expedite the implementation of her groundbreaking inventions.

Conclusion

Holly M Hankins stands out as an influential inventor whose work in developing Form II dirithromycin has the potential to improve treatment options in the medical field. Her contributions at Eli Lilly and Company reflect her commitment to innovation and excellence in pharmaceutical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…